DK2029561T3 - Tricyclisk forbindelse og farmaceutisk anvendelse deraf - Google Patents

Tricyclisk forbindelse og farmaceutisk anvendelse deraf

Info

Publication number: DK2029561T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical use; tricyclic compound; tricyclic; compound; pharmaceutical
Prior art date: 2006-06-19

Application number

DK07767453.9T

Other languages

English (en)

Inventor

Osamu Uchikawa

Tatsuki Koike

Yasutaka Hoashi

Takafumi Takai

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-19

Filing date

2007-06-18

Publication date

2014-11-10

2007-06-18 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2014-11-10 Application granted granted Critical

2014-11-10 Publication of DK2029561T3 publication Critical patent/DK2029561T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Anesthesiology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK07767453.9T 2006-06-19 2007-06-18 Tricyclisk forbindelse og farmaceutisk anvendelse deraf DK2029561T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006168518		2006-06-19
PCT/JP2007/062645 WO2007148808A1 (en)	2006-06-19	2007-06-18	Tricyclic compound and pharmaceutical use thereof

Publications (1)

Publication Number	Publication Date
DK2029561T3 true DK2029561T3 (da)	2014-11-10

Family

ID=38519675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07767453.9T DK2029561T3 (da)	2006-06-19	2007-06-18	Tricyclisk forbindelse og farmaceutisk anvendelse deraf

Country Status (36)

Country	Link
US (5)	US8030337B2 (da)
EP (1)	EP2029561B1 (da)
JP (1)	JP5222737B2 (da)
KR (1)	KR101442274B1 (da)
CN (1)	CN101506181B (da)
AR (1)	AR061478A1 (da)
AU (1)	AU2007261953B2 (da)
BR (1)	BRPI0713743C1 (da)
CA (1)	CA2655753C (da)
CL (1)	CL2007001779A1 (da)
CO (1)	CO6150175A2 (da)
CR (1)	CR10524A (da)
CY (1)	CY1115729T1 (da)
DK (1)	DK2029561T3 (da)
ES (1)	ES2523410T3 (da)
GE (1)	GEP20125392B (da)
HK (1)	HK1130049A1 (da)
HR (1)	HRP20141046T1 (da)
IL (1)	IL195639A0 (da)
JO (1)	JO2999B1 (da)
MA (1)	MA30523B1 (da)
ME (2)	ME00582A (da)
MX (1)	MX2008015842A (da)
MY (1)	MY158069A (da)
NO (1)	NO341739B1 (da)
NZ (1)	NZ574037A (da)
PE (1)	PE20080941A1 (da)
PL (1)	PL2029561T3 (da)
PT (1)	PT2029561E (da)
RS (1)	RS53616B1 (da)
RU (1)	RU2456278C2 (da)
SI (1)	SI2029561T1 (da)
TW (1)	TWI402261B (da)
UA (1)	UA99104C2 (da)
WO (1)	WO2007148808A1 (da)
ZA (1)	ZA200900151B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI402261B (zh) *	2006-06-19	2013-07-21	Takeda Pharmaceutical	三環化合物及其醫藥組成物
BRPI0722057A2 (pt) *	2006-12-28	2014-04-01	Takeda Pharmaceutical	Composto, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono, e, uso do composto.
CN103450111B (zh) *	2013-09-04	2015-07-08	温州大学	一种苯并噻唑杂环化合物的绿色合成方法
US20160253891A1 (en) *	2015-02-27	2016-09-01	Elwha Llc	Device that determines that a subject may contact a sensed object and that warns of the potential contact
CA3010727C (en) *	2016-01-08	2023-10-31	Takeda Pharmaceutical Company Limited	Prophylactic or therapeutic agent for delirium
CN108697689B (zh) *	2016-01-08	2022-04-26	武田药品工业株式会社	自闭症谱系障碍的预防或治疗剂
UA126472C2 (uk)	2016-10-19	2022-10-12	Монсанто Текнолоджі Ллс	Композиція та спосіб для зміни цвітіння та архітектури рослин для поліпшення потенційної врожайності

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1292226C (en) *	1986-01-16	1991-11-19	Terumi Hachiya	Indenothiazole derivative and process for preparing the same
FR2680366B1 (fr)	1991-08-13	1995-01-20	Adir	Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US6180657B1 (en)	1993-11-18	2001-01-30	Eli Lilly And Company	Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) *	1993-11-18	1997-08-05	Eli Lilly And Company	Melatonin derivatives for use in treating sleep disorders
FR2725985B1 (fr) *	1994-10-21	1996-11-15	Adir	Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19502895A1 (de)	1995-01-31	1996-08-01	Merck Patent Gmbh	4-Mercapto-benzoylguanidin-Derivate
CA2176854A1 (en)	1995-06-07	1996-12-08	Daniel J. Keavy	N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
US5596019A (en) *	1995-06-07	1997-01-21	Bristol-Myers Squibb Company	N-acyl-cycloalkylamine derivatives as melatonergics
US5753709A (en) *	1995-06-07	1998-05-19	Bristol-Myers Squibb Company	N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
FR2742153B1 (fr)	1995-12-12	1998-02-13	Innothera Lab Sa	Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
CN100441574C (zh)	1996-03-08	2008-12-10	武田药品工业株式会社	三环化合物及其制备和用途
US6034239A (en)	1996-03-08	2000-03-07	Takeda Chemical Industries, Ltd.	Tricyclic compounds, their production and use
SE9802360D0 (sv) *	1998-07-01	1998-07-01	Wikstroem Hakan Vilhelm	New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin
WO2001013950A1 (fr) *	1999-08-20	2001-03-01	Takeda Chemical Industries, Ltd.	Agents d'absorption percutanee
JP3633895B2 (ja) *	2000-11-17	2005-03-30	武田薬品工業株式会社	コポリビドン含有製剤
ATE469644T1 (de) *	2000-11-17	2010-06-15	Takeda Pharmaceutical	Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
US6569894B1 (en) *	2001-10-04	2003-05-27	Bristol-Myers Squibb Company	Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) *	2002-03-12	2004-05-18	Bristol-Myers Squibb Company	Benzoxazole derivatives as novel melatonergic agents
US20050197365A1 (en) *	2004-02-27	2005-09-08	Jeffrey Sterling	Diamino thiazoloindan derivatives and their use
US20060223877A1 (en)	2005-03-31	2006-10-05	Zemlan Frank P	Methods of treatment utilizing certain melatonin derivatives
TWI402261B (zh) *	2006-06-19	2013-07-21	Takeda Pharmaceutical	三環化合物及其醫藥組成物

2007
- 2007-06-15 TW TW096121686A patent/TWI402261B/zh active
- 2007-06-15 AR ARP070102638A patent/AR061478A1/es not_active Application Discontinuation
- 2007-06-18 PT PT77674539T patent/PT2029561E/pt unknown
- 2007-06-18 ME MEP-16/09A patent/ME00582A/xx unknown
- 2007-06-18 RU RU2009101299/04A patent/RU2456278C2/ru not_active IP Right Cessation
- 2007-06-18 GE GEAP200711069A patent/GEP20125392B/en unknown
- 2007-06-18 ME MEP-2014-143A patent/ME01998B/me unknown
- 2007-06-18 CL CL2007001779A patent/CL2007001779A1/es unknown
- 2007-06-18 RS RS20140609A patent/RS53616B1/en unknown
- 2007-06-18 CA CA2655753A patent/CA2655753C/en active Active
- 2007-06-18 SI SI200731532T patent/SI2029561T1/sl unknown
- 2007-06-18 AU AU2007261953A patent/AU2007261953B2/en active Active
- 2007-06-18 JO JOP/2007/0230A patent/JO2999B1/ar active
- 2007-06-18 ES ES07767453.9T patent/ES2523410T3/es active Active
- 2007-06-18 PL PL07767453T patent/PL2029561T3/pl unknown
- 2007-06-18 JP JP2008557541A patent/JP5222737B2/ja active Active
- 2007-06-18 EP EP07767453.9A patent/EP2029561B1/en active Active
- 2007-06-18 DK DK07767453.9T patent/DK2029561T3/da active
- 2007-06-18 US US12/305,560 patent/US8030337B2/en active Active
- 2007-06-18 KR KR1020097000940A patent/KR101442274B1/ko active IP Right Grant
- 2007-06-18 UA UAA200900323A patent/UA99104C2/uk unknown
- 2007-06-18 NZ NZ574037A patent/NZ574037A/en not_active IP Right Cessation
- 2007-06-18 BR BRPI0713743A patent/BRPI0713743C1/pt active IP Right Grant
- 2007-06-18 ZA ZA200900151A patent/ZA200900151B/xx unknown
- 2007-06-18 CN CN2007800308773A patent/CN101506181B/zh active Active
- 2007-06-18 PE PE2007000764A patent/PE20080941A1/es active IP Right Grant
- 2007-06-18 WO PCT/JP2007/062645 patent/WO2007148808A1/en active Application Filing
- 2007-06-18 MX MX2008015842A patent/MX2008015842A/es active IP Right Grant
2008
- 2008-12-01 IL IL195639A patent/IL195639A0/en active IP Right Grant
- 2008-12-05 MY MYPI20084958A patent/MY158069A/en unknown
- 2008-12-18 CR CR10524A patent/CR10524A/es unknown
- 2008-12-19 MA MA31489A patent/MA30523B1/fr unknown
2009
- 2009-01-14 NO NO20090234A patent/NO341739B1/no not_active IP Right Cessation
- 2009-01-19 CO CO09003953A patent/CO6150175A2/es unknown
- 2009-09-01 HK HK09107988.0A patent/HK1130049A1/xx not_active IP Right Cessation
2011
- 2011-03-14 US US13/047,363 patent/US8349879B2/en not_active Expired - Fee Related
- 2011-03-14 US US13/047,409 patent/US8236837B2/en not_active Expired - Fee Related
2012
- 2012-10-23 US US13/657,956 patent/US8552037B2/en active Active
2013
- 2013-09-04 US US14/017,819 patent/US8895591B2/en active Active
2014
- 2014-10-29 HR HRP20141046TT patent/HRP20141046T1/hr unknown
- 2014-11-07 CY CY20141100927T patent/CY1115729T1/el unknown

Also Published As

Publication number	Publication date
CA2655753A1 (en)	2007-12-27
CR10524A (es)	2009-01-27
HK1130049A1 (en)	2009-12-18
CY1115729T1 (el)	2017-01-25
NZ574037A (en)	2011-10-28
RU2009101299A (ru)	2010-07-27
RS53616B1 (en)	2015-04-30
GEP20125392B (en)	2012-02-10
ME00582A (en)	2011-12-20
AR061478A1 (es)	2008-08-27
JP2009541202A (ja)	2009-11-26
PT2029561E (pt)	2014-11-12
CN101506181B (zh)	2011-12-07
ES2523410T3 (es)	2014-11-25
NO20090234L (no)	2009-02-12
PL2029561T3 (pl)	2015-03-31
US20140011849A1 (en)	2014-01-09
WO2007148808A1 (en)	2007-12-27
ZA200900151B (en)	2010-03-31
CO6150175A2 (es)	2010-04-20
ME01998B (me)	2015-05-20
US8552037B2 (en)	2013-10-08
MA30523B1 (fr)	2009-06-01
KR20090023701A (ko)	2009-03-05
RU2456278C2 (ru)	2012-07-20
US8895591B2 (en)	2014-11-25
JO2999B1 (ar)	2016-09-05
BRPI0713743B8 (pt)	2020-05-19
TWI402261B (zh)	2013-07-21
US20110190361A1 (en)	2011-08-04
TW200815376A (en)	2008-04-01
US20110196003A1 (en)	2011-08-11
HRP20141046T1 (hr)	2014-12-19
US8349879B2 (en)	2013-01-08
MY158069A (en)	2016-08-30
CL2007001779A1 (es)	2008-01-04
UA99104C2 (uk)	2012-07-25
BRPI0713743A2 (pt)	2012-11-06
NO341739B1 (no)	2018-01-15
JP5222737B2 (ja)	2013-06-26
SI2029561T1 (sl)	2014-11-28
US8236837B2 (en)	2012-08-07
CN101506181A (zh)	2009-08-12
EP2029561A1 (en)	2009-03-04
PE20080941A1 (es)	2008-09-04
IL195639A0 (en)	2009-09-01
EP2029561B1 (en)	2014-08-13
KR101442274B1 (ko)	2014-09-22
BRPI0713743C1 (pt)	2021-05-25
US20130079374A1 (en)	2013-03-28
AU2007261953A1 (en)	2007-12-27
BRPI0713743B1 (pt)	2020-03-17
MX2008015842A (es)	2009-01-09
US20090182023A1 (en)	2009-07-16
CA2655753C (en)	2015-08-04
US8030337B2 (en)	2011-10-04
AU2007261953B2 (en)	2012-11-08

Publication	Publication Date	Title
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
DK2001556T3 (da)	2014-11-10	Thioninium-forbindelser og anvendelse deraf
DK2079485T3 (da)	2012-08-06	Phenylpropionamidforbindelser og anvendelsen deraf
DK2185164T3 (da)	2017-11-13	Sammensætning og terapeutisk antitumorvaccine
DK1884242T3 (da)	2013-05-06	Farmaceutisk sammensætning omfattende lurasidon
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK2041139T3 (da)	2012-01-16	Farmaceutiske forbindelser
DK2384754T3 (da)	2013-05-06	Farmaceutiske doseringsformer
DK1940467T3 (da)	2017-02-13	Lægemiddelsammensætning med langvarig frigivelse
DK1957073T3 (da)	2014-05-12	Lægemiddel
DK2254873T3 (da)	2014-06-30	Benzodiazepinforbindelse og farmaceutisk sammensætning.
DK2081955T3 (da)	2015-06-15	Metastinderivater og anvendelse deraf
DK2170827T3 (da)	2013-11-18	Indolin-2-oner og aza-indolin-2-oner
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
CR10725A (es)	2009-05-12	Compuestos de pirazolina y su uso y composiones farmaceuticas
DK2207773T3 (da)	2012-09-10	Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
DK1885716T3 (da)	2013-02-11	Thiazolderivater og anvendelse deraf
DK3181691T3 (da)	2020-08-17	Anti-fgf23-antistof og en farmaceutisk sammensætning omfattende samme
DK2152699T3 (da)	2011-04-18	Quinolon-forbindelse og farmaceutisk sammensætning
DK2029561T3 (da)	2014-11-10	Tricyclisk forbindelse og farmaceutisk anvendelse deraf
DK1829874T3 (da)	2014-05-12	Tricyklisk forbindelse og anvendelse deraf
EP2098513A4 (en)	2010-12-01	TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL USE
BRPI0810057A2 (pt)	2014-10-21	Composição farmacêutica contendo floroglucinol e paracetamol
DK2231603T3 (da)	2013-06-03	Substituerede 3-hydroxypyridiner og farmaceutiske sammensætninger deraf